Europe Molecular Diagnostic Analyzers and Reagents Market 2021: France, Germany, Italy, Spain, UK--Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review
|発行||Venture Planning Group||商品コード||233420|
|出版日||ページ情報||英文 1273 Pages
|欧州諸国（フランス・ドイツ・イタリア・スペイン・英国）の分子診断市場 Europe Molecular Diagnostic Analyzers and Reagents Market 2021: France, Germany, Italy, Spain, UK--Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review|
|出版日:||ページ情報: 英文 1273 Pages||
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.
This new 1,273-page comprehensive five-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Table of Contents
II. Worldwide Technology and Market Overview
A. DNA Sequencing
B. DNA and RNA Probes Technology
C. Detection Technologies
D. Instrumentation Review
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
G. Major Applications
VIII. Major Product Development Opportunities
IX. Design Criteria for Decentralized Testing Products
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
XII. Competitive Assessments
Contains 1,273 pages and 139 tables